血清IgA、IgA/C3和IgA/C4比值在IgA型肾病临床鉴别诊断中的应用

[1]

ROBERT T,BERTHELOT L,CAMBIER A,et al.Molecular insights into the pathogenesis of IgA nephropathy[J].Trends Mol Med,2015,21(12):762.

[2]

WYATT RJ,JULIAN BA.IgA nephropathy[J].N Engl J Med,2013,368(25):2402.

[3]

SAKAI H,ABE K,KOBAYASHI Y,et al.Clinical guidelines of IgA nephropathy[J].Nihon Jinzo Gakkai Shi,1995,37(8):417.

[4]

付莎,徐安平,李劲高.血清IgA及IgA/C3比值用于IgA肾病的诊断价值——附180例报告[J].新医学,2010(10):658.

[5]

汤颖,马小琨,张俊,等.血清IgA,C3及IgA/C3与IgA肾病诊断及病理分级的关系[J].中华全科医学,2010,8(1):17.

[6]

KOMATSU H,FUJIMOTO S,HARA S,et al.Relationship between serum IgA/C3 ratio and progression of IgA nephropathy[J].Int Med,2004,43(11):1023.

[7]

祝爽爽,李永强,周树录,等.血清中IgA/C3比值在IgA肾病诊断预测中的价值及其与IgA肾病临床及病理联系[J].南方医科大学学报,2015,35(12):1683.

[8]

刘林林,刘楠,王娟,等.肾小球C4d沉积为IgA肾病的预后因子[J].中国医科大学学报,2017,46(1):23.

[9]

吴春林.肾病病人免疫球蛋白、补体、白蛋白、血脂与肾脏病理的关系[J].检验医学,2013,28(5):370.